Catch the InSphero Team at ACT 2026!
Join us at the American College of Toxicology (ACT) Annual Meeting 2026 in San Antonio, Texas, where toxicologists, researchers, and industry leaders will come together to explore the latest advances in toxicological science, drug safety, and predictive preclinical research.
We look forward to connecting with the community to discuss how physiologically relevant, reproducible, and scalable 3D in vitro models can advance safety assessment, provide deeper insights into human biology, and support more informed decision-making throughout drug development.
Exchange perspectives with experts in New Approach Methodologies (NAMs), drug-induced liver injury (DILI), gastrointestinal (GI) toxicity, and species-specific toxicology, and discover how innovative approaches can strengthen preclinical safety assessment.
Explore our activities during the ACT 47th Annual Meeting, from November 15–18, 2026. See you in San Antonio!
ACT 2026 Booth
Our Booth at ACT 2026
Visit our booth #103 andand discover our 3D InSight™ Liver Safety Services – Practical and Predictive 3D In Vitro Models for DILI Risk Assessment:
ACT 2026 EHS
3D InSight Liver and Gastrointestinal Models: Comprehensive Tools for Nonclinical Safety Assessment
Date: Wednesday, November 18th, 2026
Time: 12:00-12:55 pm
Location: Grand Oaks P
DRUG-Seq in Practice: Ultra-High-Throughput Transcriptomics for Compound Triage and Safety Liability Assessment
Date: Monday, November 16th, 2026
Time: 12:00-12:55 pm
Location: Grand Oaks S
Poster Presentation at ACT 2026
Early Safety Assessment in Liver Microtissues Using Low-Input RNA-Seq and Mechanistic Studies Across Species and Compound Analogs
Date: Monday, November 16th, 2026
Time: 5:00 – 6:30pm